AZELASTINE HYDROCHLORIDE ALLERGY Drug Patent Profile
✉ Email this page to a colleague
When do Azelastine Hydrochloride Allergy patents expire, and when can generic versions of Azelastine Hydrochloride Allergy launch?
Azelastine Hydrochloride Allergy is a drug marketed by Apotex and is included in one NDA.
The generic ingredient in AZELASTINE HYDROCHLORIDE ALLERGY is azelastine hydrochloride. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Azelastine Hydrochloride Allergy
A generic version of AZELASTINE HYDROCHLORIDE ALLERGY was approved as azelastine hydrochloride by APOTEX INC on April 30th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AZELASTINE HYDROCHLORIDE ALLERGY?
- What are the global sales for AZELASTINE HYDROCHLORIDE ALLERGY?
- What is Average Wholesale Price for AZELASTINE HYDROCHLORIDE ALLERGY?
Summary for AZELASTINE HYDROCHLORIDE ALLERGY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 46 |
DailyMed Link: | AZELASTINE HYDROCHLORIDE ALLERGY at DailyMed |
Recent Clinical Trials for AZELASTINE HYDROCHLORIDE ALLERGY
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
MEDA Pharma GmbH & Co. KG | Phase 2 |
Sandoz | Phase 1 |
Mermaid Medicine® | N/A |
Pharmacology for AZELASTINE HYDROCHLORIDE ALLERGY
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for AZELASTINE HYDROCHLORIDE ALLERGY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apotex | AZELASTINE HYDROCHLORIDE ALLERGY | azelastine hydrochloride | SPRAY, METERED;NASAL | 216421-001 | May 29, 2024 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |